CORC

在结果中检索

CORC

浏览/检索结果: 共89条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Blocking ROR1 enhances the roles of erlotinib in lung adenocarcinoma cell lines 期刊论文
ONCOLOGY LETTERS, 2019, 卷号: 18, 期号: 3, 页码: 2977-2984
作者:  Wang, Hui-Li;  Liu, Yan-Chun;  Long, Ming-Peng;  Zheng, Chuan;  Yang, Jia-Hui
收藏  |  浏览/下载：98/0  |  提交时间：2019/11/07
Erlotinib inhibits colon cancer metastasis through inactivation of TrkB-dependent ERK signaling pathway 期刊论文
JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 卷号: 120, 期号: 7
作者:  Li, Yunfeng;  Shen, Tao;  Cheng, Xianshuo;  Xia, Cuifeng;  Li, Qiang
收藏  |  浏览/下载：26/0  |  提交时间：2019/12/04
Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study 期刊论文
LUNG CANCER, 2019, 卷号: 130
作者:  Wu, Yi-Long;  Zhou, Caicun;  Lu, Shun;  Qin, Shukui;  Pan, Hongming
收藏  |  浏览/下载：23/0  |  提交时间：2019/12/05
Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study 期刊论文
LUNG CANCER, 2019, 卷号: 130, 页码: 18-24
作者:  Wu, Yi-Long;  Zhou, Caicun;  Lu, Shun;  Qin, Shukui;  Pan, Hongming
收藏  |  浏览/下载：28/0  |  提交时间：2019/11/19
Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study 期刊论文
Lung Cancer, 2019, 卷号: Vol.130, 页码: 18-24
作者:  Yi-Long Wu;  Caicun Zhou;  Shun Lu;  Shukui Qin;  Hongming Pan
收藏  |  浏览/下载：15/0  |  提交时间：2019/12/17
Asian  Chemotherapy  EGFR  Erlotinib  Non  small  cell  lung  cancer  
Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China. 期刊论文
Lung Cancer, 2019, 卷号: Vol.127, 页码: 84-89
作者:  Gu, Xiaohua;  Zhang, Qiang;  Chu, Yun-Bo;  Zhao, Yi-Yang;  Zhang, Yan-Jun
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/17
Impact of ErbB Mutations on Clinical Outcomes in Afatinib- or Erlotinib-Treated Patients with SCC of the Lung 会议论文
作者:  Goss, G.;  Cobo, M.;  Lu, S.;  Syrigos, K.;  Lee, K. H.
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: a retrospective, multicenter study 期刊论文
BMC PULMONARY MEDICINE, 2018, 卷号: 18
作者:  Jiang, Ye;  Zhang, Jing;  Huang, Juanjuan;  Xu, Bo;  Li, Ning
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Exosome-mediated transfer of lncRNA RP11-838N2.4 promotes erlotinib resistance in non-small cell lung cancer 期刊论文
INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 卷号: 53, 期号: 2
作者:  Zhang, Wei;  Cai, Xinrui;  Yu, Jie;  Lu, Xuxiang;  Qian, Qiuhai
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Erlotinib-Guided Self-Assembled Trifunctional Click Nanotheranostics for Distinguishing Druggable Mutations and Synergistic Therapy of Nonsmall Cell Lung Cancer 期刊论文
MOLECULAR PHARMACEUTICS, 2018, 卷号: 15, 页码: 5146-5161
作者:  Gao, Yu;  Zhang, Huijuan;  Zhang, Yingying;  Lv, Tingting;  Zhang, Lu
收藏  |  浏览/下载：7/0  |  提交时间：2019/11/21

©版权所有 ©2017 CSpace - Powered by CSpace